Faviravir 200 Tablet

About Faviravir 200 Tablet

Faviravir 200 is an antiviral tablet containing favipiravir 200 mg. It is used for pandemic influenza when other antiviral medicines are not effective enough. Doctors decide the dose and course.

There are 9 brands of Favipiravir listed in Bangladesh. The lowest listed price is Favivir 200 mg Tablet at ৳ 200.00 per unit.

What is Faviravir 200 Tablet?

Faviravir 200 is a tablet medicine with the active ingredient favipiravir. It belongs to a group of medicines called antiviral drugs. It is used for the treatment of novel or re-emerging pandemic influenza virus infections. It is reserved for cases where other influenza antiviral drugs are ineffective or not sufficiently effective. The medicine works by blocking the influenza virus from multiplying inside the body. It is available as a 200 mg tablet. The doctor decides the appropriate dose and duration of treatment for each patient.

Uses of Faviravir 200

Faviravir 200 is used to treat novel or re-emerging pandemic influenza virus infections. It is prescribed when other influenza antiviral medicines are not effective or not sufficiently effective. It is not for common colds or other viral illnesses. Only a registered doctor can decide if this medicine is suitable for a particular patient.

How to use Faviravir 200

Faviravir 200 is taken by mouth as a tablet. The doctor will decide the dose, how often to take it, and how many days the course should last. Swallow the tablet with water. Do not change the dose or stop the course without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Faviravir 200

The most common side effects of favipiravir are diarrhea and an increase in blood uric acid levels. These are the side effects reported for the medicine. If you experience diarrhea or any other unusual symptom while taking Faviravir 200, tell your doctor. Your doctor may check your blood uric acid levels during treatment. Do not treat side effects on your own without medical advice.

Safety and precautions

Faviravir 200 must not be given to pregnant women or women who may possibly be pregnant. It may cause harm to the developing embryo. Women who could become pregnant need a pregnancy test before starting treatment and must use thorough contraception from the start of treatment until seven days after the end of treatment. Caution is needed in patients with liver or kidney problems. Tell your doctor about any liver or kidney condition, pregnancy, or breastfeeding before taking this medicine. The doctor decides if it is suitable for you.

Frequently asked questions

What does the 200 mg strength and tablet form mean?

Faviravir 200 comes as a tablet, which is a solid form taken by mouth. Each tablet contains 200 mg of the active ingredient favipiravir. The doctor decides how many tablets you need and for how long. Do not change the dose yourself.

What is Faviravir 200 used for and what kind of medicine is it?

Faviravir 200 is an antiviral medicine. It is used to treat novel or re-emerging pandemic influenza virus infections when other influenza antiviral drugs are ineffective or not sufficiently effective. It is not for common colds. Your doctor will decide if it is right for you.

Is Faviravir 200 safe in pregnancy or breastfeeding?

Faviravir 200 must not be used during pregnancy because it may harm the developing baby. Women who could become pregnant need a pregnancy test before treatment and must use contraception during treatment and for seven days after. Ask your doctor about breastfeeding before taking this medicine.

Who should ask a doctor before taking Faviravir 200?

Anyone with liver or kidney problems should ask a doctor before taking Faviravir 200. Women who are pregnant, may be pregnant, or are breastfeeding must talk to a doctor first. Always follow your doctor's advice about dose and course.

Indications

Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective).

Pharmacology

Favipiravir is a new antiviral drug against influenza. It is metabolized into favipiravir ribosyl triphosphate (favipiravir RTP) by an intracellular enzyme, and favipiravir RTP selectively inhibits RNA polymerase (RNA-dependent RNA polymerase) of the influenza virus, preventing replication of the influenza virus. It is a drug with a mechanism of action different from that of the existing influenza antiviral drugs and effective against all types and sub-types of human influenza A, B, and C viruses in vitro, showing a wide range of anti-viral activity against various influenza virus strains including avian and swine viruses.

Dosage & Administration

The usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5 or as directed by physicians. The total treatment duration should be 5 days.

Interaction

In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.

Contraindications

Favipiravir is contraindicated for pregnant women and women who may possibly be pregnant.

Side Effects

Most common side effects are Diarrhea and increase of blood uric acid levels.

Pregnancy & Lactation

Favipiravir may cause delayed development or death of embryos during the early stage of pregnancy. Should not be given during pregnancy.

Precautions & Warnings

Favipiravir should not be given in pregnant women, requirement of the confirmation of non-pregnancy in women of childbearing potential before use, thorough contraception measures from the start of the treatment to 7 days after the end of the treatment. Caution should be taken for Hepatic and renal impaired patient or use Favipiravir as per the direction of registered Physician

Overdose Effects

In animal studies, decreased RBC production,and increases in liver function parameters such as AST, ALP, ALT and total bilirubin, and increased vacuolization in hepatocytes. Toxicity information regarding Favipiravir in humans is not readily available.

Storage Conditions

Keep below 30°C temperature, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Favipiravir

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.